STOCK TITAN

Cosette Pharmaceuticals Appoints Brad Leonard as Vice President, Generics Commercial Operation

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management

Cosette Pharmaceuticals has appointed Brad Leonard as Vice President of Generics Commercial Operations to drive its next growth phase. Leonard will lead the company's generics business, including Sales, Marketing/Pricing, Customer Service, and Demand Planning. With over 30 years of pharmaceutical industry experience, Leonard previously contributed to Upsher-Smith Laboratories' success, earning multiple HDMA Diana Awards for product excellence and company performance.

President and CEO Apurva Saraf highlighted Leonard's deep industry expertise and track record in driving commercial success and strategic partnerships. Leonard, who holds a B.S. in Business Administration & Management from the University of Minnesota, expressed enthusiasm about joining Cosette during its period of accelerated growth and portfolio expansion.

Cosette Pharmaceuticals ha nominato Brad Leonard Vice President delle Operazioni Commerciali dei Farmaci Generici per guidare la sua prossima fase di crescita. Leonard dirigerà il business dei farmaci generici dell'azienda, inclusi Vendite, Marketing/Pricing, Servizio Clienti e Pianificazione della Domanda. Con oltre 30 anni di esperienza nel settore farmaceutico, Leonard ha precedentemente contribuito al successo di Upsher-Smith Laboratories, guadagnando numerosi premi HDMA Diana per l'eccellenza del prodotto e le performance aziendali.

Il Presidente e CEO Apurva Saraf ha evidenziato la profonda esperienza di Leonard nel settore e il suo storico successo commerciale e nelle partnership strategiche. Leonard, che possiede una laurea in Business Administration & Management presso l'Università del Minnesota, ha espresso entusiasmo per l’ingresso in Cosette durante questo periodo di crescita accelerata e espansione del portafoglio.

Cosette Pharmaceuticals ha nombrado a Brad Leonard como Vicepresidente de Operaciones Comerciales de Genéricos para impulsar su próxima fase de crecimiento. Leonard liderará el negocio de genéricos de la compañía, incluyendo Ventas, Marketing/Precios, Servicio al Cliente y Planificación de la Demanda. Con más de 30 años de experiencia en la industria farmacéutica, Leonard contribuyó previamente al éxito de Upsher-Smith Laboratories, ganando múltiples premios HDMA Diana por la excelencia del producto y el rendimiento de la empresa.

El Presidente y CEO Apurva Saraf destacó la profunda experiencia en la industria de Leonard y su historial en impulsar el éxito comercial y asociaciones estratégicas. Leonard, que posee una licenciatura en Administración de Empresas y Gestión de la Universidad de Minnesota, expresó su entusiasmo por unirse a Cosette durante su periodo de crecimiento acelerado y expansión de portafolio.

코제트 제약브래드 레너드를 일반의약품 상업 운영 부사장으로 임명하여 다음 성장 단계를 이끌 예정입니다. 레너드는 회사의 일반의약품 사업을 이끌며, 판매, 마케팅/가격 책정, 고객 서비스 및 수요 계획을 포함합니다. 제약 산업에서 30년 이상의 경력을 쌓은 레너드는 이전에 업셔-스미스 실험실의 성공에 기여하며 여러 HDMA 다이애나 상을 수상한 바 있습니다.

회장 겸 CEO인 아푸르바 사라프는 레너드의 깊은 산업 전문성과 상업적 성공 및 전략적 파트너십을 이끄는 실적을 강조했습니다. 미네소타 대학교에서 경영학 학사 학위를 보유한 레너드는 코제트에서의 자리잡기와 포트폴리오 확장의 가속화된 성장 기간에 합류하게 되어 매우 기쁘다고 전했습니다.

Cosette Pharmaceuticals a nommé Brad Leonard au poste de Vice-Président des opérations commerciales des génériques pour diriger sa prochaine phase de croissance. Leonard sera responsable de l'activité génériques de l'entreprise, y compris les ventes, le marketing/pricing, le service client et la planification de la demande. Fort de plus de 30 ans d'expérience dans l'industrie pharmaceutique, Leonard a précédemment contribué au succès d'Upsher-Smith Laboratories, remportant plusieurs prix HDMA Diana pour l'excellence des produits et les performances de l'entreprise.

Le président et PDG Apurva Saraf a souligné l'expertise approfondie de Leonard dans le secteur et son parcours en matière de succès commercial et de partenariats stratégiques. Leonard, qui détient un B.S. en administration des affaires et gestion de l'Université du Minnesota, a exprimé son enthousiasme à rejoindre Cosette pendant cette période de croissance accélérée et d'expansion de portefeuille.

Cosette Pharmaceuticals hat Brad Leonard zum Vizepräsidenten für die kommerziellen Aktivitäten im Bereich Generika ernannt, um die nächste Wachstumsphase voranzutreiben. Leonard wird das Generikageschäft des Unternehmens leiten, einschließlich Vertrieb, Marketing/Preisgestaltung, Kundenservice und Bedarfsplanung. Mit über 30 Jahren Erfahrung in der Pharmaindustrie hat Leonard zuvor zum Erfolg von Upsher-Smith Laboratories beigetragen und mehrere HDMA Diana Awards für Produktqualität und Unternehmensleistung gewonnen.

Präsident und CEO Apurva Saraf hob Leonards umfassende Branchenerfahrung und seine Erfolge bei der Förderung des kommerziellen Erfolgs und strategischer Partnerschaften hervor. Leonard, der einen B.S. in Betriebswirtschaft und Management von der University of Minnesota hält, drückte seine Begeisterung darüber aus, während der Phase des beschleunigten Wachstums und der Portfoliowachstums zu Cosette zu stoßen.

Positive
  • Appointment of experienced executive with 30+ years of industry expertise
  • Proven track record with multiple HDMA Diana Awards for excellence
  • Strategic expansion of generics business operations
Negative
  • None.

Experienced commercial leader joins Cosette to drive the next phase of growth and transformation

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cosette Pharmaceuticals, Inc., a leading specialty pharmaceuticals company, today announced the appointment of Brad Leonard as Vice President, Generics Commercial Operations. In this role, Brad will spearhead Cosette’s generics business, including Generics Sales, Marketing/Pricing, Customer Service, and Demand Planning, as the company continues its expansion in these markets.

Brad Leonard, Vice President, Generics Commercial Operations (Photo: Business Wire)

Brad Leonard, Vice President, Generics Commercial Operations (Photo: Business Wire)

“Cosette is in the midst of an exciting period of accelerated growth and portfolio expansion, and Brad is the right commercial leader to take our business to the next level,” said Apurva Saraf, President and CEO, Cosette Pharmaceuticals. “Brad’s deep expertise in the pharmaceutical industry, combined with his track record of driving commercial success and fostering strategic partnerships, will be a catalyst for our continued momentum.”

Brad played a pivotal role in the growth and success of Upsher-Smith Laboratories, LLC using a customer-focused approach to enhance their financial performance and commercial presence - demonstrated by over eight HDMA Diana Awards for product excellence and overall company performance.

“I am honoured to join Cosette at this pivotal moment in its journey,” said Brad Leonard, Vice President, Generics Commercial Operations. “The company’s bold vision, entrepreneurial spirit, and relentless focus on innovation make this an incredibly exciting time to be part of the team. I look forward to collaborating with the talented individuals at Cosette to accelerate our commercial execution, expand our market reach, and set new standards of excellence for the customers and patients we serve.”

With 30+ years of experience in the pharmaceutical industry, Brad is an experienced pharmaceutical executive with a robust background in pharmaceutical access and patient delivery across both generic and branded markets, cultivating and sustaining strong customer relationships, developing award-winning commercialization teams, and consistently driving sales and profit growth.

Brad holds a B.S. in Business Administration & Management from the University of Minnesota.

About Cosette Pharmaceuticals:

Cosette Pharmaceuticals, Inc. (“Cosette”) is a US-based, fully integrated pharmaceutical company with a fast-growing portfolio of branded pharmaceuticals consisting of products in women’s health, cardiology and dermatology. Cosette has a long history in quality manufacturing of complex dosage forms including topical creams, ointments, oral liquids/solutions and suppositories. Cosette has corporate and manufacturing facilities in New Jersey and North Carolina and is supported by 350+ dedicated team members across all functional areas. Cosette is backed by Avista Healthcare Partners, a healthcare focused private equity firm, and funds managed by Hamilton Lane, a private markets investment management firm (NASDAQ: HLNE). For more information, please visit www.cosettepharma.com and follow us on LinkedIn.

Business Development: bd@cosettepharma.com

Commercial: sales@cosettepharma.com

Source: Cosette Pharmaceuticals, Inc.

FAQ

What role will Brad Leonard assume at Cosette Pharmaceuticals?

Brad Leonard has been appointed as Vice President of Generics Commercial Operations at Cosette Pharmaceuticals, where he will lead the generics business, including Sales, Marketing/Pricing, Customer Service, and Demand Planning.

What is Brad Leonard's professional background and experience?

Brad Leonard has over 30 years of experience in the pharmaceutical industry, with a successful track record at Upsher-Smith Laboratories, where he earned multiple HDMA Diana Awards for product excellence and company performance.

How does Brad Leonard's appointment align with Cosette Pharmaceuticals' strategy?

The appointment aligns with Cosette's period of accelerated growth and portfolio expansion, leveraging Leonard's expertise to enhance commercial execution and market reach in the generics business.

What are Brad Leonard's key responsibilities at Cosette Pharmaceuticals?

Brad Leonard will spearhead Cosette's generics business operations, overseeing Generics Sales, Marketing/Pricing, Customer Service, and Demand Planning functions.

Hamilton Lane Incorporated

NASDAQ:HLNE

HLNE Rankings

HLNE Latest News

HLNE Stock Data

6.65B
37.73M
9.67%
96.22%
4.27%
Asset Management
Investment Advice
Link
United States
CONSHOHOCKEN